Evaluating failure, re-intervention, and safety outcomes of bevacizumab as an adjunct to trabeculectomy: A systematic review and meta-analysis
AJO International · 2026-07 · 3 (2) · 100254
DOI: 10.1016/j.ajoint.2026.100254 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift AJO International, 2026-07. Verfasst von Abdus Samad Ansari und 6 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ansari, A. S., Ramji, S., Tan, J. C., Ansari, D. M., Jarrar, Z. A., Hamid, S., & Gazzard, G. (2026). Evaluating failure, re-intervention, and safety outcomes of bevacizumab as an adjunct to trabeculectomy: A systematic review and meta-analysis. AJO International, 3(2), 100254. https://doi.org/10.1016/j.ajoint.2026.100254
Vancouver
Ansari AS, Ramji S, Tan JC, Ansari DM, Jarrar ZA, Hamid S, et al. Evaluating failure, re-intervention, and safety outcomes of bevacizumab as an adjunct to trabeculectomy: A systematic review and meta-analysis. AJO International. 2026;3(2):100254. doi:10.1016/j.ajoint.2026.100254
BibTeX
@article{Ansari2026,
author = {Ansari, Abdus Samad and Ramji, Saajan and Tan, Jeremy C.K. and Ansari, Daniyal Matin and Jarrar, Zakariya A and Hamid, Sana and Gazzard, Gus},
title = {Evaluating failure, re-intervention, and safety outcomes of bevacizumab as an adjunct to trabeculectomy: A systematic review and meta-analysis},
journal = {AJO International},
year = {2026},
volume = {3},
number = {2},
pages = {100254},
doi = {10.1016/j.ajoint.2026.100254}
}
EUVIMED